Asthma and COPD Drug Market Expected to Reach USD 26,965.5 Million Globally in 2017: Transparency Market Research
3 Pages
English

Asthma and COPD Drug Market Expected to Reach USD 26,965.5 Million Globally in 2017: Transparency Market Research

Downloading requires you to have access to the YouScribe library
Learn all about the services we offer

Description

Asthma and COPD Drug Market Expected to Reach USD 26,965.5 Million Globally in 2017: Transparency Market Research PR Newswire ALBANY, New York, June 18, 2012 ALBANY, New York, June 18, 2012 /PRNewswire/ -- According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Asthma and COPD Drug Market - Global Industry Analysis, Market Size, Share, Trends, Growth and Forecasts, 2010 - 2017", the global asthma and COPD market was worth USD 25,102.3 million in 2010, which is expected to reach USD 26,965.5 million in 2017 with a CAGR of 1.03% over the forecasted period (2010 - 2017). Asthma drug segment dominated the overall asthma and COPD market at USD 14,509.1 million in 2010. The COPD segment was estimated to be worth USD 10,593.2 million in 2010, which is expected to reach USD 12,619.8 million in 2017. Browse the full report athttp://www.transparencymarketresearch.com/asthma-and-copd- market.html In the next five years, the global asthma and COPD drug market is expected to grow slowly, primarily because of expiry of patents of leading drug brands and price erosion in the market. However, by 2017, few novel drugs are expected to enter the asthma and COPD market, which will drive future growth. The existing asthma and COPD market is mainly driven by increasing patient population.

Subjects

Informations

Published by
Reads 10
Language English
Asthma and COPD Drug Market Expected to
Reach USD 26,965.5 Million Globally in 2017:
Transparency Market Research
PR Newswire
ALBANY, New York, June 18, 2012
ALBANY, New York
,
June 18, 2012
/PRNewswire/ --
According to a new market report published by Transparency Market Research
(http://www.transparencymarketresearch.com) "
Asthma and COPD Drug
Market - Global Industry Analysis, Market Size, Share, Trends, Growth
and Forecasts, 2010 - 2017
", the global asthma and COPD market was
worth
USD 25,102.3 million
in 2010, which is expected to reach
USD 26,965.5
million
in 2017 with a CAGR of 1.03% over the forecasted period (2010 - 2017).
Asthma drug segment dominated the overall asthma and COPD market at
USD
14,509.1 million
in 2010. The COPD segment was estimated to be worth
USD
10,593.2 million
in 2010, which is expected to reach
USD 12,619.8 million
in
2017.
Browse the full report
athttp://www.transparencymarketresearch.com/asthma-and-copd-
market.html
In the next five years, the global asthma and COPD drug market is expected to
grow slowly, primarily because of expiry of patents of leading drug brands and
price erosion in the market. However, by 2017, few novel drugs are expected
to enter the asthma and COPD market, which will drive future growth. The
existing asthma and COPD market is mainly driven by increasing patient
population. The other factors that will drive the market include long term use of
asthma and COPD drugs, increase in disposable income and improved access
to medical care facilities in emerging economies.
The asthma market is witnessing intense competition due to the increased
entry of inhaled corticosteroids, combinational therapies, and beta-agonists. It
is expected that Advair, Symbicort and Singulair would be the leading drugs of
the global asthma and COPD market, while Merck, GlaxoSmithKline, and
AstraZeneca will continue to be the market leaders till the patents on their
drugs expire in the coming years.
The opportunities in the asthma and COPD market is huge as many companies
are focusing on contract manufacturing outsourcing (CMO) and large players
have entered this market with new product development. Increase in
awareness about the benefits of timely diagnosis for asthma and COPD and
availability of healthcare equipment for the detection of asthma and COPD in
rural areas will further boost the market and growth opportunities for market
players.
In
China
, growth in urbanization and change in lifestyle has projected sharp
increase in occurrence of asthma in the recent years. The occurrence of
asthma symptoms is higher in urban areas as compared to rural areas. Air
pollution and smoking are the most important factors which have led to the
rapid increase in asthma and COPD patients in
China
.
The report presents detailed analysis and forecast for the global asthma and
COPD market based on the following segmentation:
Product Types
Bronchodilators
Short Acting Bronchodilators
Long Acting Bronchodilators
Anticholinergics
Anti-Inflammatories
Inhaled Corticosteroids
Anti-Leukotriene
Monoclonal Antibodies
Combination Therapies
Related & Recently Published Reports by Transparency
Market Research
Surgical Equipment Market
Weight Management Market
Prostate Cancer Market
Diabetes Market
Urological Catheters Market
CT Market
Baby Care Products Market
MRI Market
Cardiovascular Devices Market
Ground Mount PV Utility Market
Browse all Pharmaceutical Market
Research Reports
Upcoming Reports in Pharmaceutical Market
ePharmacies Market
Personalized Medicines Market
Cardiac Pacemakers Market
Advanced Parenteral Drug Delivery Devices Market
Healthcare Supplies Market
Mobile Health Market
Hospital Supplies Market
HPV Testing Market
Disinfectant Equipments Market
Contraceptives Market
Home Healthcare Market
Ablation Technologies Market
About Us
Transparency Market Research is a global market intelligence company,
providing global business information reports and services. Our exclusive blend
of quantitative forecasting and trends analysis provides forward-looking insight
for thousands of decision makers. We are privileged with highly experienced
team of Analysts, Researchers, and Consultants, who use proprietary data
sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research
experts, so that it always reflects the latest trends and information. With a
broad research and analysis capability, Transparency Market Research employs
rigorous primary and secondary research techniques in developing distinctive
data sets and research material for business reports.
Contact
Sheela AK
90 Sate Street, Suite 700
Albany, NY
12207
Tel: +1-518-618-1030
USA
- Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Blog:
http://www.tmrblog.com/
Site:
Market Research Reports